Pharmacologic Therapy for New York Heart Association Class IV Heart Failure
نویسندگان
چکیده
منابع مشابه
Cardiac resynchronization therapy in New York Heart Association class IV heart failure: it is all about selection.
In recent years, cardiac resynchronization therapy (CRT) has emerged as an important therapeutic strategy in patients with advanced heart failure. It has become common practice to use CRT in combination with implantable cardioverter-defibrillator (so-called CRT-D) in patients with impaired left ventricular systolic function and New York Heart Association (NYHA) class III symptoms.1 Evidence is ...
متن کاملCardiac resynchronization therapy in patients with New York Heart Association class I and II heart failure: an approach to 2010.
It has been firmly established that cardiac resynchronization therapy (CRT) reduces symptoms and decreases morbidity and mortality1–6 in a subgroup of patients who remain in moderate to severe chronic heart failure (HF) (New York Heart Association [NYHA] class III/IV) despite optimal medication. These patients are characterized by wide QRS on the surface ECG as a sign of ventricular dyssynchron...
متن کاملNovel Perioperative Pharmacologic Therapy Of Heart Failure
Heart failure (HF) is a pathophysiological condition with an inability of the heart to fill or eject blood sufficient to meet metabolic demands. The etiology of HF appears evenly distributed between systolic and diastolic dysfunction and currently is the only cardiac condition with an increasing mortality rate. As the elderly population grows, so will the frequency of HF patients presenting to ...
متن کاملEffects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
BACKGROUND Cardiac resynchronization therapy (CRT) alone or combined with an implantable defibrillator (CRT-D) has been shown to improve exercise capacity and quality of life and to reduce heart failure (HF) hospitalizations and mortality in patients with New York Heart Association (NYHA) class III and IV HF. There is concern that the device procedure may destabilize these very ill class IV pat...
متن کاملSurvival in New York Heart Association class IV heart failure patients treated with cardiac resynchronization therapy compared with patients on optimal pharmacological treatment.
AIMS Although the benefit of cardiac resynchronization therapy (CRT) in selected patients with heart failure is well established, its effect on mortality in New York Heart Association (NYHA) class IV patients remains unclear. Our study evaluated the effect of CRT on urgent transplant-free survival in NYHA class IV patients treated with CRT, compared with medication-only treatment. METHODS AND...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Congestive Heart Failure
سال: 2011
ISSN: 1527-5299
DOI: 10.1111/j.1751-7133.2011.00235.x